Epiminder Limited Stock: price and insider trades · Australia

This page follows insider dealings at Epiminder Limited as filed with ASX, a company from the Healthcare & Pharma sector. From 18 October 2025 to 18 October 2026, the disclosure feed for Epiminder Limited logged 6 filings by 4 insiders.

No insider sold shares on the market over the period. Instead, the filings list 6 purchases totalling €56k, made by 4 insiders. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. At €29k, the purchase published on 18 August 2026 by Donal O’Dwyer is the largest of the period (0.074% of market cap). Among those who bought: 4 senior executives.

For context, the typical company on the same exchange (median of 2,222 companies) published 3 filings over the same period, against 6 filings here. Looking back to 2026, when coverage begins, insiders filed 6 purchases and no sales.

Within a 30-day window, 4 purchases overlapped with buying by a second insider. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (20 August 2026) now reads 59 days. Between a trade and the moment it shows up on ASX, the median delay is 2 days. This delay matters because a trade only becomes useful information once it is public.

Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. Source: insider filings from ASX. Past trades are no guide to future returns.